Affymetrix Announces Preliminary Fourth Quarter Revenue of $84 Million and Implements Corporate Restructuring to Accelerate Path to Profitability

SANTA CLARA, Calif. -- Affymetrix, Inc., (NASDAQ: AFFX) today announced that based on preliminary financial data, the Company expects total revenue for the fourth quarter of 2012 will be approximately $84 million, including $18 million from its eBioscience business unit. Excluding eBioscience, the Company’s revenue increased by 1% as compared to the fourth quarter of [...]

Genedata Screener for HCS Advances Phenotypic Screening

San Francisco, Calif. -- Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced it will demonstrate Genedata Screener’s phenotypic screening capabilities at the 10th Annual High Content Analysis (HCA) Conference. Genedata Screener® for High Content Screening (HCS) covers complete screening analysis from cell-level data to final campaign [...]

Umetrics announces global sales partnership with Sartorius Stedim Biotech

Malmö, Sweden, -– Umetrics announces that they have entered into a global sales partnership with Sartorius Stedim Biotech (SSB), a leading international pharmaceutical and biotech supplier. Under the cooperation agreement SSB will embed Umetrics technology into SSB products. SSB will assume global marketing and distribution of the Umetrics portfolio of Chemometrics software for the pharmaceutical [...]

Leica Biosystems Introduces New Novocastra HD Antibody Menu for Head and Neck Pathology

The Novocastra™ HD menu for head and neck pathology comprises six antibodies[#], each selected following extensive customer research and independent evaluation* by external QA. The menu is the second portfolio of antibodies to launch from the new Novocastra HD range, following on from the introduction of the Novocastra HD menu for breast pathology in October [...]

Phenomenex Releases Updated Product Guide for 2013/2014 in Print and Digital Formats

Torrance, CA - Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the publication of its updated product and services guide for 2013/2014. Covering the company's comprehensive lines of HPLC columns, UHPLC columns, GC columns and sample preparation products, this year's catalog includes many new offerings, [...]

Promega Introduces Magne Protein A Beads for Antibody Purification

Promega Corporation announced today that it has launched Magne™ Protein A Beads for the purification of monoclonal and polyclonal antibodies from a range of diverse sources. These paramagnetic affinity beads offer a convenient method for achieving high purity and high recovery of immunoglobulins (Igs) from cell culture, ascites and serum samples. They may also be [...]

Trinean launches the Xpose, a new micro-volume spectrophotometer

Ghent, Belgium –- Trinean, the leading provider of microfluidic spectrophotometry platforms, today announced the launch of the Xpose, a new microvolume spectrophotometer for high speed quantification of 1 to 16 nucleic acid or proteins samples. The design of the Xpose and its microfluidic slides, redefines manual UV/VIS quantification into a convenient, high speed solution. The [...]

100K Pathogen Genome Project Selects PacBio SMRT(R) DNA Sequencing to Generate High-Quality, Finished Genomes

MENLO PARK, Calif., -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) provider of the PacBio® RS High Resolution Genetic Analyzer, and the University of California, Davis (UC Davis) today announced a partnership for the 100K Pathogen Genome Project. As part of the project, Pacific Biosciences' Single Molecule, Real-Time (SMRT®) technology will be used to sequence the [...]

Boston Children’s Hospital and Life Technologies Launch Claritas Genomics, a Clinical Genomics Company

SAN FRANCISCO, Calif. – Boston Children’s Hospital has partnered with Life Technologies Corporation (NASDAQ: LIFE) to launch Claritas Genomics, a new company formed to develop next-generation, genetic and genomics-based diagnostic testing solutions. The venture combines advanced instrumentation, software and bioinformatics capabilities with sophisticated clinical interpretation of test results and consultation by specialist physicians and medical [...]

WaferGen BioSystems Announces Highly Successful Initial Customer Testing of Previously Unannounced Novel Target Enrichment Technology for Next-Gen Sequencing (NGS)

FREMONT, Calif., — WaferGen Bio-systems, Inc. (OTCBB: WGBS) today announced the successful completion of a proof-of-concept study using its newly-developed proprietary nano-qPCR technology for sample preparation prior to targeted re-sequencing on Next-Gen platforms. The results can be viewed in white paper form at: Target enrichment with uniform coverage approaching 100% is difficult to achieve with [...]

Access IBO on Knowledge Center